VEGFC and Pulmonary lymphangiectasia: Interestingly, in a mouse model of VEGF-C induced pulmonary lymphangiectasia, which persisted even after normalization of VEGF-C levels, Rapamycin treatment effectively promoted regression of abnormal lymphatic vessels without affecting normal vessels39.